Two Sigma Securities’s Elevation Oncology ELEV Stock Holding History

Two Sigma Securities’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,717	Closed	-$4.67K	–	1555
2025 Q2	$4.67K	Sell	12,717 -6,154	-33%	-$2.05K	﹤0.01%	1365
2025 Q1	$4.89K	Sell	18,871 -43,509	-70%	-$24.8K	﹤0.01%	1303
2024 Q4	$35.1K	Buy	+62,380	New	+$36.8K	﹤0.01%	1229
2023 Q4	–	Sell	-23,776	Closed	-$15.8K	–	3161
2023 Q3	$15.8K	Buy	+23,776	New	+$24K	﹤0.01%	2611

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Two Sigma Securities's ELEV Position: Q3 2025 in Review

Two Sigma Securities sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 12,717 shares — an estimated $4.67K sold.

Two Sigma Securities first reported a position in ELEV in Q3 2023 and held it in 4 quarters. The position peaked at $35.1K in Q4 2024. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Two Sigma Securities reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Two Sigma Securities sold 12,717 Elevation Oncology shares in Q3 2025, an estimated $4.67K.
Two Sigma Securities first reported a position in Elevation Oncology in Q3 2023 and held it in 4 quarters.
Two Sigma Securities's Elevation Oncology position peaked at $35.1K in Q4 2024.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.